We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.2B
AUM Growth
-$2.64B
(-3.2%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 2 |
JPMorgan Chase
JPM
|
+$525M |
| 3 |
JD.com
JD
|
+$297M |
| 4 |
Itaú Unibanco
ITUB
|
+$222M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$955M |
| 2 |
Citigroup
C
|
+$523M |
| 3 |
Nektar Therapeutics
NKTR
|
+$334M |
| 4 |
SLB Ltd
SLB
|
+$292M |
| 5 |
Alibaba
BABA
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Consumer Discretionary | 14.85% |
| 3 | Healthcare | 13.25% |
| 4 | Technology | 13.05% |
| 5 | Energy | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRG
526
DELISTED
HRG Group, Inc.
HRG
| $23.5M | 0.03% |
1,422,359
-554,913
| -28% | -$9.27M |
|
527
American International
AIG
$42.9B
| $23.4M | 0.03% |
430,869
-1,464,425
| -77% | -$86.5M |
|
|
BLD
528
DELISTED
TopBuild
BLD
| $23.4M | 0.03% |
305,436
+20,509
| +7% | +$1.55M |
|
529
Synaptics
SYNA
$4.33B
| $23.3M | 0.03% |
510,562
-2,129
| -0.4% | -$96.6K |
|
530
Neogen
NEOG
$2B
| $23.3M | 0.03% |
695,244
-157,641
| -18% | -$4.75M |
|
|
MDCO
531
DELISTED
Medicines Co
MDCO
| $23.2M | 0.03% |
705,383
-3,451
| -0.5% | -$108K |
|
532
TAL Education Group
TAL
$5.79B
| $23.2M | 0.03% |
625,750
-142,310
| -19% | -$4.88M |
|
533
Valero Energy
VLO
$88.7B
| $23.2M | 0.03% |
249,915
-60,571
| -20% | -$5.65M |
|
|
MBFI
534
DELISTED
MB Financial Corp
MBFI
| $23.1M | 0.03% |
571,403
+2,540
| +0.4% | +$110K |
|
535
Bio-Techne
TECH
$11.2B
| $23.1M | 0.03% |
612,352
-728
| -0.1% | -$25.7K |
|
536
TransUnion
TRU
$16.2B
| $23.1M | 0.03% |
406,674
+40,156
| +11% | +$2.32M |
|
|
DLPH
537
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $22.7M | 0.03% |
476,374
-3,840
| -0.8% | -$199K |
|
538
Prestige Consumer Healthcare
PBH
$2.45B
| $22.3M | 0.03% |
661,966
-284,065
| -30% | -$10.9M |
|
539
Lamb Weston
LW
$7.51B
| $22.1M | 0.03% |
379,780
+36,847
| +11% | +$2.09M |
|
|
TCF
540
DELISTED
TCF Financial Corporation Common Stock
TCF
| $22M | 0.03% |
401,524
-410
| -0.1% | -$23.1K |
|
541
Trex
TREX
$4.57B
| $21.8M | 0.03% |
801,364
+261,104
| +48% | +$7.19M |
|
542
Primerica
PRI
$10B
| $21.7M | 0.03% |
224,773
+17,577
| +8% | +$1.77M |
|
|
SHPG
543
DELISTED
Shire pic
SHPG
| $21.7M | 0.03% |
145,270
+2,430
| +2% | +$335K |
|
|
HES
544
DELISTED
Hess
HES
| $21.7M | 0.03% |
427,968
-292,816
| -41% | -$14.4M |
|
545
OceanFirst Financial
OCFC
$1.74B
| $21.6M | 0.03% |
809,141
-6,414
| -0.8% | -$173K |
|
546
Dorman Products
DORM
$4.28B
| $21.6M | 0.03% |
326,602
+315,925
| +2,959% | +$22.5M |
|
|
PPLI
547
People Inc
PPLI
$3.13B
| $21.6M | 0.03% |
771,920
+184,083
| +31% | +$4.85M |
|
548
Semtech
SMTC
$10.4B
| $21.6M | 0.03% |
552,367
-284,159
| -34% | -$10.2M |
|
549
Werner Enterprises
WERN
$2.3B
| $21.4M | 0.03% |
586,978
+569,758
| +3,309% | +$22.2M |
|
550
Edwards Lifesciences
EW
$48.2B
| $21.3M | 0.03% |
457,758
+444,009
| +3,229% | +$19.3M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2018 Portfolio in Review
As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
- OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
- OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
- OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
- OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
- OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
- OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.
Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.